CELL INTELLIGENCE · 肿瘤细胞治疗研究

αvβ3 CAR-T 细胞同时靶向肿瘤和转移灶，在黑色素瘤和三阴性乳腺癌的临床前模型中产生高度有效的控制

αvβ3 CAR-T Cells Simultaneously Targeting Tumor and Metastases Produce Highly Effective Control in Preclinical Models of Melanoma and Triple-Negative

儿童黑色素瘤：新兴疗法与正在进行的临床试验

Pediatric Melanoma: Emerging Therapies and Ongoing Clinical Trials.

CAR-T 治疗的疗效、安全性和成本效果

Efficacy, safety and cost-effectiveness of CAR-T therapy.

免疫治疗和小分子癌症治疗对生育力的影响：当前证据、机制和未来方向的叙述性综述

Impact of immunotherapy and small molecule cancer therapy on fertility: a narrative review of current evidence, mechanisms and future directions.

泛素特异性蛋白酶 6 mRNA 脂质纳米颗粒在尤文肉瘤中激发抗肿瘤免疫并抑制肿瘤发生

Ubiquitin-Specific Protease 6 mRNA Lipid Nanoparticles Ignite Antitumor Immunity and Suppress Tumorigenesis in Ewing Sarcoma.

靶向 NY-ESO-1 的保守高亲和力 TCR 工程化 CD4 TCR T 细胞用于癌症晚期细胞治疗

Engineered CD4 TCR T cells with conserved high-affinity TCRs targeting NY-ESO-1 for advanced cellular therapies in cancer.

在黑色素瘤中探索免疫检查点抑制剂和新型免疫疗法的前景：长期结局、进展与挑战

Navigating the landscape of immune checkpoint inhibitors and novel immunotherapies in melanoma: long-term outcomes, progress, and challenges.

抗 MCAM CAR 修饰扩增 NK 细胞联合 NKTR-255 抗神经母细胞瘤的联合免疫治疗

Combinatorial immunotherapy of anti-MCAM CAR-modified expanded natural killer cells and NKTR-255 against neuroblastoma.

通过联合固有免疫治疗规避 Ewing 肉瘤微环境中的耐药性

Circumventing resistance within the Ewing sarcoma microenvironment by combinatorial innate immunotherapy.

我们的临床前研究表明，通过先天免疫系统进行的免疫疗法，即结合靶向肿瘤的 CAR-NK 细胞与 IL-15 激动剂和 CD47 阻断，是一种有前景的新型治疗方法，可用于靶向 MCAM 高恶性转移性 ES。

间充质干细胞来源细胞外囊泡改善青春期狂饮样乙醇处理诱导海马 NLRP3 炎症的新兴作用

The emerging role of mesenchymal stem cell-derived extracellular vesicles to ameliorate hippocampal NLRP3 inflammation induced by binge-like ethanol t